Imidazole → HCID 178481629、化合物

HRID 76334

反応式

HRID 76334 の反応式
[CH3:1][N:2]1[C:6](=[O:7])[C:5](=O)[NH:4][C:3]1=[O:9].N1C=CN=C1.C(N(CC)CC)C.Cl[Si](C)(C)C.[CH2:27]([NH2:34])[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1>C(Cl)(Cl)Cl.O>[CH2:27]([NH:34][C:5]1[C:6](=[O:7])[N:2]([CH3:1])[C:3](=[O:9])[N:4]=1)[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1

参加物

8

実験手順

To a solution of 1-methyl-imidazolidine-2,4,5-trione (Example 1.3, Part A) (800 mg, 6.25 mmol), imidazole (467 mg, 6.87 mmol), N,N-dimethylaminopyridine (cat.) and triethylamine (1.82 mL, 13.1 mmol) in chloroform (13 mL) was added chlorotrimethylsilane (1.67 mL, 13.1 mmol) dropwise at room temperature under a nitrogen atmosphere, and the reaction mixture was stirred for 2 h. Benzylamine (0.75 mL, 6.87 mmol) was added and the reaction mixture was stirred for a further 22.5 h. The reaction mixture was diluted with chloroform and water and the chloroform extracts were dried and evaporated. The crude product was purified by column chromatography (PS with gradient elution to DCM:EtOAc 3:1) to give the product as a colourless solid (838 mg, 62%), mp 152-154° C. δH (300 MHz, CD3CN) 7.95 (v br s, 1H, NH), 7.41-7.27 (m, 5H, PhH), 4.64 (s, 2H, CH2), 2.95 (s, 3H, CH3). Mass spectrum (ESI) m/z 218 (M+H).

後処理

  1. stirringthe reaction mixture was stirred for a further 22.5 h
  2. dry with materialthe chloroform extracts were dried
  3. customevaporated
  4. customThe crude product was purified by column chromatography (PS with gradient elution to DCM:EtOAc 3:1)

出典と根拠

ORDレコード
ord-acce0bf81faf4463902c8f37549108b5
出典データセット
uspto-grants-2014_09
特許番号
US08835629B2

関連ノート

読み込み中…